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INTRODUCTION
The great concern of cancer worldwide is expanding 
its shadows to scientific fields previously far from a 
forthright relation with oncology. Besides to the aware-
ness that malnutrition and some incorrect dietary hab-
its and lifestyles are possible triggers for cancer onset, 
current literature is moving its spotlight on the fun-
damental role exerted by the different adipose tissues 
in this regards [1-3]. The adipocyte is a highly complex 
cell, despite its simplistic image of a fat-collecting tank. 
Current evidence is emerging about the fundamental 
role of the adipocyte as the master tuner of tissue ho-
meostasis, cross talking with resident immunity and 
stem cells, where even long non coding RNAs might 
have a major regulatory commitment [4-7]. In this con-
text, oxidative stress has been long time considered a 
leading factor in carcinogenesis [8]. Furthermore, the 
relationship between nutrition intake, dietary habits 
and different lifestyles with oxidative burden and 
stress response has been widely and thoroughly ad-
dressed so far [9]. The relationship between obesity and 
cancer might be an interesting vanishing point to focus 
onto the real function of the different adipose tissues 
in humans.
A first question may regard which relationship does 
exist between adipose tissue, metabolism and cancer. 
This issue is of the utmost importance to shed light 
on the actual role exerted by different dietary habits 
on cancer onset and development. The relationship be-
tween diabetes and cancer is particularly striking [10,11]. 
Actually, obese subjects are particularly at risk for 
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cancer ethiopathogenesis, though controversial opin-
ions were also forwarded [12-16]. This evidence would 
suggest that the role of adipocytes in this context is 
particularly striking. Interestingly, due to their lipid 
storage, adipocytes might be even considered as stray 
mines for cancer pathogenesis. Adipocyte-derived lipids 
may change cancer drug resistance [17] and noteworthy 
free fatty acids from the adipose tissue are important 
biomarkers for cancer, as they elicit or even modulate 
an immuno-inflammatory response [18-20]. Yet, the 
role of fats in our complex biology and physiology is 
not so trivial as suspected only few decades ago and 
therefore even human daily diet to prevent cancer, 
when addressing fats, should not follow any prejudicial 
and widespread fashion about fats in the diet, as fats 
are powerful regulators of the complex cross talk adi-
pose tissue-immunity-tissue turn over. The role of fat 
molecules, particularly short chain fatty acids, polyun-
saturated fatty acids (PUFAs) and more, are currently 
emerging as fundamental molecules in men’s health, 
as cancer preventive substances [20-24]. The complete, 
though complex, picture that is emerging from current 
literature is that the adipocyte is at the cross road of a 
regulatory network, linking immunity, stress response 
and cell cycle (with the consequent associated stem 
mechanisms), where lipids and reactive oxygen species 
(ROS) act as major signaling molecules. Briefly speak-
ing, the participation of lipids and ROS in creating a 
master tuner of tissue homeostasis, the leading mecha-
nism that, once disturbed or impaired may cause can-
cer, is no less fundamental than cytokines and growth 
factors [25-29]. This overview strongly suggests that lip-
ids intake in the daily diet must be only highly moni-
tored and regulated, not quite completely removed, as 
the commonest opinion about diet habits would en-
courage. Particularly for men’s health, an unbalanced 
diet provided with an excess of protein intake, exceed-
ing the Recommended Dietary Assumptions, alongside 
with poor fats introduction, can be a potential risk for 
carcinogenesis, although this evidence yet needs to be 
further assessed [30-33]. For example, a low protein 
intake, both from animals and plants, in an isocaloric 
diet, without necessarily following a low-carbohydrate 
nutritional panel, decreases cancer risk due to a deple-
tion in the CD8+ T cell and antigen presenting cells, 
mounting an anti-immune response and lowering the 
inflammatory reaction. This occurrence is related to 
the triggering of an unfolded protein response in can-
cer cells, a mechanism ignited via the activation of the 
inositol requiring enzyme 1-alpha and retinoic acid in-
ducible gene 1 signaling pathway, resulting in an anti-
cancer activity [33].
The role of diet in tuning the adipose tissue function 
is of the utmost importance. This role is closely as-
sociated with further two major components in men’s 
health, namely the gut microbiome brain axis and the 
musculoskeletal system. The relationship between the 
skeletal muscle fiber and the adipocyte is emerging in 
the very recent years, through the role of myokines [34]. 
The muscle secretome has an important role in modu-
lating the aforementioned role of the adipose tissue in 
tuning the mechanism of tissue homeostasis, where 
molecules, such as brain-derived neurotrophic factor 
and interleukin (IL)-6 directly participate in the AMP-
activated protein kinase-mediated lipid oxidation [34]. 
In this context, even the turn over of ROS is addressed 
to regulate muscular optimal activity and cell survival, 
contrarily to the widespread opinion that ROS are del-
eterious despite their signaling function [35]. Therefore, 
the synoptic picture we might draw from this perspec-
tive is that oxidative stress and nutrients such as fats 
are collectively bridled to be used as signaling elements 
for the complex cross talk with tissues that the adipose 
tissue exerts in its main function.
In this review I am going to deepen and discuss this 
issue.
A NOVEL HYPOTHESIS ABOUT 
THE INTRIGUING ROLE OF THE 
ADIPOSE TISSUE (THE FUNCTIONAL 
METASTABILITY OF THE 
ADIPOCYTE)
So far, the role of  the adipose tissue, and conse-
quently of the adipocyte as its key cell model, has been 
ultimately confined to the trivial image of a fat reser-
voir, with the only fundamental purpose to modelling 
anatomic regions as a sort of “plastic wax”. However, 
in recent years this commonly widespread view on the 
adipose tissue has been questioned somehow, by at-
tributing to the adipocyte a major immuno-modulatory 
role in the organism [36]. Immune function has been 
long time considered a quite distinct issue respect to 
bio-energetics, taking it aside from the metabolic and 
endocrine commitment with which the adipose tissue 
should be really engaged. Yet, a huge deal of reports 
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has recently moved the spotlight on the adipocyte as 
a leading actor in the complex immune-tissues cross 
talk [37-40]. Despite this, current research did not yet 
distinguished any purported existence of an exclusive 
adipocyte-immune cell from the common adipocyte col-
lecting fats in the white adipose tissue (WAT) [36]. On 
the contrary, the scientific community attributed to the 
mature adipocyte in WAT the ability to modulate the 
immune function alongside its main task of lipid stor-
age [41-43]. This allows the adipocyte to be described as 
having a sort of “secret” double life. Therefore, besides 
its endocrine role in fat storage, the adipocyte would be 
an immune-like cell tout court, inasmuch the adipose 
tissue was recently considered a tertiary lymphoid 
organ [44]. Obviously, this raises many interesting 
questions about the actual role of the adipose tissue in 
cancer pathogenesis and development [1,45]. 
So, is the adipocyte a multi-task cell? 
Actually, WAT was reported to home both regula-
tory T cells (Tregs) and group 2 innate lymphoid cells 
(ILC2s), keeping the immune function in the tissues 
under check, a role tuned by IL-33 from the stromal 
vascular fraction (SVF) [46]. A very recent paper ac-
tually showed that lineage negative (lin-) SVF cells, 
which express the platelet-derived growth factor recep-
tor alpha (PDGFR-α) and Sca-1, whereas they lack of 
the endothelial, hematopoietic and erythroid cell mark-
ers CD31, CD45, and Ter111, are active producers of IL-
33 [46]. These cells showed typical genotypic features 
associated with adipose stem and progenitor cells, as 
expressing CD34, Itgb1 (CD29), Ly6a (Sca-1), Pdpd, 
and Pdgfrα genes [46]. Although IL-33 has been so 
far considered a master tuner of innate immunity, its 
very recent role is to maintain WAT homeostasis [47]. 
This cytokine is particularly intriguing, as it has been 
recently related with nutrition, due to the observation 
that IL-33 regulates the inflammatory process dur-
ing obesity [48]. Therefore, we are discovering that the 
adipocyte is not only a fundamental player for the im-
mune homeostasis in WAT but even that immune me-
diators serve as tuners of the adipose tissue turnover. 
Conversely, typical adipocyte products, such as lipid 
droplets, act as immune modulators [49].
A complex immune-adipocyte-tissue plasticity net-
work has inflated the current debate on fat biology 
also in further men’ health concern, such as aesthetic 
surgery. This still raises these questions: which role the 
adipocyte is fundamentally committed to, an immune 
or a plastic one? Or both? Or have we to turn our at-
tention to a “third” option? Probably, the adipocyte 
might be considered a sort of sentinel of the “bodily 
self”, by checking and tuning the correct balance of 
different tissue types and their dynamics alongside the 
immune system [50-52].
So, the linkage with stem functions would suggest 
that the interplay between the adipose tissue and im-
munity should have a more demanding role than the 
simple check of a healthy metabolic homeostasis. An 
immuno-modulatory role, via a paracrine pathway, has 
been very recently recognized to mesenchymal stem 
cells (MSCs) [53-55], particularly close to the adipocyte 
biology, so suggesting that the adipocyte might lay at 
the crossroad immunity/stem-tissue homeostasis, so 
even suggesting for immunity a wider role within the 
classical well known immune self. In this perspective, 
the adipocyte tells of itself as a highly complex cell, 
finely tuning fundamental and strategic functions in 
the maintenance of tissue homeostasis, behaving in a 
much more intriguing way than expected and standing 
quite far from the sole acknowledged role of a lipid-
tank collector. Actually, the very recent reports regard-
ing the adipocyte, would suggest for a new outstanding 
activity in the “strange” life of the adipocyte, i.e., the 
adipocyte as a master tuner of tissue homeostasis, not 
merely a regulator of a more general metabolic steady 
state. This feature may have important consequences 
on the comprehension of cancer development.
An intriguing functional kinship with MSCs of he-
matopoietic origin, sharing apparently a common role 
in maintaining the biological self via immunity, might 
shed light on the unusual and attractive “existence” of 
the adipocyte and on the real role of the adipose tissue, 
which may be of the utmost importance in tissue plas-
ticity [56-58]. The adipocyte life cycle itself should give 
us insightful clues about the complex activity exerted 
by the adipose tissue in this perspective.
The first conundrum we should address is whether 
the white mature adipocyte is a commonly stable, dif-
ferentiated cell or exhibiting a certain marked tuning 
ability in its adipose lifecycle. The most widespread 
view of the differentiated adipocyte is that it is the 
resulting outcome of  the adipogenetic pathway of 
mesenchymal precursors, usually collectively known 
as pre-adipocytes. The term pre-adipocytes may be yet 
outdated, as panoply of adipocyte precursors, called 
adipocyte progenitor cells (APCs), participate indeed in 
https://doi.org/10.5534/wjmh.190167
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the tissue/stem cell homeostasis, which is ultimately 
ruled by the adipose tissue, as previously suggested [59-
62]. The master tuner of pre-adipoyte maturation into 
adult adipocytes is peroxisome proliferator-activated 
receptor gamma (PPAR-γ), but further agonists and 
modulators have been reported to be involved in this 
mechanism [63,64]. The APC population is formed by 
cells of mesenchymal origin (MSCs), fibroblast-like 
cells and a heterogeneous population of cells in the 
SVF [60,61] of the adipose tissue. Many APCs can be 
easily identified and isolated [65]. Most of the current 
research on the adipocyte lifecycle has been carried out 
on laboratory animals, such as mice or rats. In mice, 
WAT precursors were identified as PDGFR-α+ cells 
with the phenotype CD24+, but also the CD24- stem 
precursors Lin-:CD29+:CD34+:Sca-1+:CD24- were identi-
fied in the APC population, so suggesting that CD24+ 
cells would generate CD24- cells in vivo. CD24 nega-
tive cells will express late markers of the adipogenetic 
process, i.e., behaving as pre-adipocytes [62]. The loss of 
CD24 marker may commit APCs to the further adipo-
cyte development [62].
This perspective may shed light on the modulatory 
role of the adipocyte in tissue homeostasis, encompass-
ing many further issues of men’s health, i.e., aging and 
cancer pathogenesis.
SVF precursors express CD34 (as stem cells) and 
CD29, whereas did not express peculiar markers of 
endothelium or hematopoietic lineage, such as CD31, 
CD45, and Ter111 [62]. Recent reports showed that in 
mice at least four subgroups of APCs in SVF can be 
identified on the basis of the expression of CD29 and 
CD34 but more than half of this population express the 
stem cell antigen 1 (Sca-1), being Lin-:CD29+;CD34+:Sca-1+, 
being also CD105- and CD117-, whereas only a small 
proportion expressed CD24 [62]. Interestingly, in trans-
genic mice (A-Zip) lacking of WAT, a dramatic increase 
in APCs also in the SVF population occurred, with a 
huge enhancement in the expression of differentiation 
genes and early markers of adipogenesis, such as Klf4, 
C/EPB-δ and Krox20, alongside a marked reduction of 
PPAR-γ [62]. This evidence suggests that SVF contains 
many stem cells that are not directly committed to 
become adipocytes unless the occurrence of the expres-
sion of defined markers and that a possible feedback 
circuitry might exist between stem cell precursors and 
mature adipocytes [66]. Therefore, this complex balance 
stem precursors/mature adipocytes, if confirmed, should 
encompass the ability of mature cells to revert into 
potential stem lineages. Fig. 1 summarizes one possible 
model of the complex life cycle of a WAT adipocyte.
In this regard, a fundamental role should be exerted 
by lipids released by the adipocyte, as signaling mol-
ecules in the complex cross talk with other tissues. 
Actually, mature adipocytes can undergo depilidation. 
Delipided adipocytes might be apparently considered 
aged adipocytes rapidly loosing lipids ad entering the 
“senescent” phase of fibrblast-like post-adipocytes but 
further suggestions were forwarded [67]. Yet, delipida-
tion of mature fat cells was already described in past 
reports [68]. Delipidation is also associated with the in-
volutive occurrence of terminally-described adipocytes, 
which appear particularly during sustained stress: the 
post-adipocytes.
This mechanism makes the adipocyte as a function-
ally “metastable” cell, in the sense that its stability is 
not of morphological type by of dynamical one [69].
Furthermre, post-adipocytes have been described 
in past reports [70] but recently restyled as a mature 
adipocyte able to resist the massive damage and stress, 
causing lipid loss, which usually occurs also during 
lipoaspiration procedures and fat grafting, and to 
rebuild functional fat cells [67]. Therefore the post-
adipocyte is all but a terminal, out of service adipocyte. 
There might be, therefore, a close relationship between 
the mechanism of delipidation and the occurrence of 
post-adipocytes. Delipided adipocytes suggested in the 
past the hypothesis that mature most-mitotic adipo-
cytes may not be terminally differentiated, yet [71]. 
Delipided adipocyte can give rise de novo to mature, 
fully functional adipocytes [72]. We still do not know if 
the shift from a post-adipocyte to a mature adipocyte 
crosses pathways including pre-adipocytes or adipocyte 
derived stem cells (ADSCs) as precursors of newly adi-
pogenetic cellular pools. To elucidate if post-adipocytes 
develop into mature adipocyte via an ADSC, this cell 
should express, for example, some specific phenotypic 
markers, such as CD90, CD44, CD29, CD105, CD13, 
CD34, CD73, CD166, CD10, CD49e, and CD59 and possi-
bly be negative for markers, such as CD31, CD45, CD14, 
CD11b, CD19, CD56, and CD146 [73]. Further insights 
are needed to elucidate this issue.
Furthermore, delipidation may be a highly controlled 
physiological process, which can occur in ADSCs and 
leave adipocytes alive, neither undergoing apoptosis or 
autophagic mechanisms, nor dedifferentiation [74]. For 
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example, a controlled nano-induced in situ hyperther-
mia, causes adipocyte delipidation [74]. Interestingly, 
hypothermia inhibits bone-marrow derived MSCs 
and increases resistance to hypoxic stress by the SU-
MOylation of fundamental proteins, such as PCNA, 
oct-4, p53, and HIF-1α [75]. This evidence suggests that 
delipidation may be a physiological mechanism of stress 
response. It is possible to speculate that delipidation 
caused by stress, may induce a population of ADSCs 
which over-expressing heat shock protein-70, enhancing 
the success and the efficacy of the autologous fat graft-
ing in men’s aesthetic health [76]. Further research 
should address if this population of ADSCs may derive 
from the delipidation/post-adipocyte route (Fig. 1).
Finally, a dedifferentiation process of the mature ad-








































Fig. 1. Hypothesis of the adipocyte life cycle in white adipose tissue. The common routinely pathway is indicated in the centre of the figure (large 
thick arrows), suggesting the pathway pre-adipocyte-mature adipocyte-delipided adipocyte, which then evolves to a post-adipocyte. This can 
give rise to adipocytes (1), adipocyte derived stem cells (ADSCs), which then will evolve to adipocytes directly (2) or via a pre-adipocytic pathway 
(3). Moreover, mature adipocytes can evolve to dedifferentiated adipose tissue (DFAT) cells (4), which might be confused with the stem pool of 
fibrblast-like cells. In this pool, stromal vascular fraction (SVF) cells are precursors of CD24 non expressing stem cells, which will give rise to white 
adipocytes (5), while the CD24+ SVF pool, which represent the stem cell population together with mesenchymal stem cells (MSCs) (6) will origi-
nate beige adipocytes (7). Factors produced by cells (inside the panel) and soluble mediators (out of the panel), which act in this process, are indi-
cated. PPAR: peroxisome proliferator-activated receptor, BMP: bone morphogenetic protein.
https://doi.org/10.5534/wjmh.190167
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(dedifferentiated adipose tissue, DFAT cells) with fibro-
blast-like phenotype [77]. There are controversial opin-
ions about DFAT cells, i.e., if these fibroblast-like cells 
evolved from adipocytes and can reconstitute a new 
functional adipose tissue (practically post-adipocytes) or 
if they are true dedifferentiated adipocytes with stem 
potential [78]. The ambiguity is that fibroblast-like cells 
inducing new connective cell phenotype may be typical 
MSCs from the stem pool and not merely DFAT cells 
[78]. Anyway, this type of cells seem to emerge during a 
massive loosening of adipose tissue, when stress condi-
tions should induce a fibrotic response [77,78].
THE ROLE OF NUTRITION-DERIVED 
LIPIDS AND REACTIVE OXYGEN 
SPECIES
Following the hypothesis suggested in Fig. 1, mature 
adipocyte in WAT looses lipids in response to stress-
ors, such as ROS and enters a proactive rejuvenation, 
even passing via a stem phenotype. If confirmed, lipids 
should exert a fundamental signaling role in the mech-
anism described above about the adipocyte life cycle. 
Our idea is that adipocytes may “go back” to a relative-
ly younger stage (delipided) and then, depending on the 
microenvironment conditions, turn again to a mature 
phenotype or even reaching a stem phenotype, which 
usually has an adipogenetic commitment. This latest 
pathway should assure the adipose tissue to enhance 
its expansion potential. The balance adipocyte precur-
sors/mature adipocytes is fundamental to warrant for 
a correct anatomical plasticity and tissue homeostasis, 
a condition that allows to consider the adipocyte a 
“quasi-stable” or metastable cell, though indicated as a 
post-mitotic, differentiated cell.
Nutrition has a leading role in this sense.
Recent evidence reported, for example, that dietary 
conjugated linoleic acid (CLA) reduces the fat burden 
in adipocytes, i.e., promoted the formation of delipided 
adipocytes. For example, trans-10 and cis-12 CLA but 
not cis-9 and trans-11 CLA, when added to stromal 
vascular cells in cell cultures containing newly dif-
ferentiated human adipocytes, caused time-dependent 
dampening of the trigliceride content, insulin-stimu-
lated glucose and fatty acid uptake. These same CLAs 
diminished also PPAR-γ and many PPAR-γ induced 
genes and increased leptin gene expression. The ro-
bust activation of the MEK/ERK signaling preceded 
changes in gene expression and caused the release of 
IL-6 and IL-8. Interestingly, the MEK/ERK activation 
by trans-10 and cis-12 CLA was inhibited by UO126 
and pertussis toxin [79]. According to these authors, 
trans-10 and cis-12 CLA, delipided mature adipocytes 
by inducing the MEK/ERK signaling via an autocrine/
paracrine action of adipocytokines, IL-6 and L-8 [79].
In would be particularly interesting to investigate 
if these lipids are spontaneously formed in vivo and, if 
yes, in which biochemical, physiological (or pathologi-
cal) stage.
The role of the trans-10, cis-12 as antagonists of li-
pidic storage has been widely demonstrated in recent 
reports [80-83]. This CLA is therefore associated with 
caloric restriction, anti-obesity molecule, anti-lipid stor-
age factor. Interestingly, this PUFA induces mature 
adipocyte delipidation [79]. The question is if these lip-
ids are typical signaling mediators of the process in the 
adipocyte life cycle described before. While the isomer 
cis-9, trans-11 induces adipogenesis [84], it is possible to 
speculate on the existence of cell of “on/off switchers” 
tuning the ratio t10,c12-CLA/c9,t11 CLA, as they play 
also a fundamental role in immunity [85]. We yet do 
not know if adipocytes may have enzymatic switching 
regulators (as a switch of two double C-C bonds, cis-
trans, shifted of one position towards the ω6 end with 
reciprocal isomerization) At least 24 isomers of the 
18:2, ω-6 linoleic acid were described [86]. Some studies 
have investigated the role of CLAs in adipocyte dif-
ferentiation. The geometric isomer trans-10, cis-12 CLA 
reduces the number of pre-adipocytes [87] and inhibits 
glycerol-3-phosphate dehydrogenase, while cis-9 and 
trans-11 antagonized the other [87]. Futhermore, t10,c12 
CLA inhibited the expression of PPAR-γ and of sterol 
regulatory element-binding protein-1c (SREBP-1c) [87] 
and did not affect the expression of CCAAT/enhancer 
binding protein alpha (C/EBP-α), therefore t10,c12 CLA 
cannot be considered a regulator of adipogenesis but of 
lipid storage and of the balance pre-adipocytes/mature 
adipocytes, i.e., of delipidation [87,88]. The isomer t10,c12 
CLA may induce also inflammation [89]. Moreover, at 
least in porcine models, CLAs regulates adipogenesis in 
vascular stromal cells [90]. In these models, t10,c12-CLA 
inhibits adipogenesis in subcutaneous adipose tissue 
and promotes adipogenesis in intramuscular adipose 
tissue [91].
Usually, CLAs are obtained by an α9 desaturase. 
In adipocytes PUFAs are regulated by the fatty acid 
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desaturase FADS1 and FADS2 [91]. In adipocytes lin-
oleic acid is the main tuner of FADS gene expression 
[91]. Therefore, it is tempting to speculate that CLAs 
are intrinsic regulators of the adipocyte “biomass” in 
sub-epidermal layers, where, in this perspective, it is 
conceivable that fibroblasts and keratinocytes may be 
fundamental sources of linoleic acid. Linoleic acid, in 
the presence of β-NADH, elicits a rapid and immediate 
ROS production in fibroblasts, which most probably act 
as signaling molecules to activate fibroblast oxidative 
burst [92].
It is also well known that ROS induce adipocyte dif-
ferentiation via an increased expression of PPAR-γ and 
activating the CCAAT/enhancer-binding protein β (C/
EBP-β) [93]. Anyway, this adipocyte differentiation oc-
curs, at least in colture, if cells reach the confluence 
and under ROS oxidation. In this conditions, in the 
constant presence of inducing hormones, adipocytes 
activate PPAR-γ and differentiate into mature adi-
pocytes and ROS enhanced cell phase S during the 
mitotic clonal expansion [93]. This is quite probably, 
the commonest, most orthodox circumstance regarding 
adiposity modulation in sub-epidermal fat tissues. De-
tached adipocytes are more likely to loss lipids and to 
enter a route of dedifferentiation, while adipocytes still 
present in a whole adipose tissue respond to the afore-
mentioned cycle.
Conversely, ROS might activate also dedifferenti-
ated adipocytes, most probably via a Notch/NADPH 
oxidase 4 interplay, but usually when ROS exceed a 
certain threshold, probably evaluated by mitochondria 
oscillation [94-96]. According to this hypothesis, there 
must exist a lipid signaling as a sort of “warning” sig-
nal, able to induce the adipocyte to shifting towards 
“younger” phenotypes and so enabling the adipose tis-
sue to respond to the stressful stimulus maintaining 
the tissue homeostasis of the organism. Much ADSCs 
and dedifferentiated adipocytes might be therefore 
elicited when a defined “threshold”, probably induced 
by a certain milieu of soluble factors and cytokines, 
is overwhelmed, usually quite far from physiological 
conditions. Further research should yet elucidate this 
issue.
The role of ROS is therefore fundamental as a sig-
naling pathway to set the adipocyte at the crossroad 
of the complex interplay energetic metabolism/tissue 
homeostasis. Therefore, they have a fundamental ac-
tion also in the evolution of cancer, taking into account 
these issues.
The extreme plasticity of the adipocyte is a leading 
cause of many tumors, due to the occurring impair-
ment in this complex cross talk [97].
In this perspective, the different type of adipose tis-
sues in humans and the different types of fat composi-
tion in adipocytes, should exert a fundamental role in 
tissue homeostasis, so driving the complex signaling 
machinery preventing cancer in the organism.
Fats are therefore signaling molecules as well as 
ROS, a perspective that should raise the question if 
fats and ROS are more friends than foes for men’s 
health. A first interesting evidence is the role of lipids 
stored in cells as lipid droplets to counteract oxida-
tive stress and move onward the metabolic-energetic 
machinery of cells [98]. Actually, lipid droplets are able 
to tune cell oxidative stress [99]. According to some 
authors, lipid droplets have the main property to buf-
fer and modulate the delayed release of fats, both as 
signaling molecules and metabolic sources, and the 
delayed release is fundamental for many purposes, 
such as energy and redox homeostasis, tuning of au-
tophagy [100] and of the ER stress [99]. In this sense, 
lipids actively participate as mediators in the cross talk 
between cells and tissues. Lipids in diet are therefore 
fundamental as possible elements in the creation of a 
complex signaling language among cells and within 
cells [101].
In this landscape, ROS may have also a fundamental 
task.
PPAR-γ and autophagy are intertwined in control-
ling both ROS signaling and lipid droplets produc-
tion and turn over, having therefore a role in some 
type of cancer, such as colon cancer [102]. Actually, 
the role of PPAR-γ is more intriguing than expected, 
as it may tune the so called “two-compartment tumor 
metabolism” model, where a metabolic coupling has 
been suggested to occur between catabolic stromal cells 
and oxidative tumor cells [103]. In this models, cancers, 
for example breast cancer, is embedded in a complex 
microenvironment where a cross talk cancer cells/stro-
mal cells occurs, in order to tune cancer survival. This 
cross talk involves also adipocytes. Cancer cells elicit in 
stromal cells glycolysis, lipid droplets, ROS formation 
from mitochondria and autophagy, while stromal cells 
activate a response with onco-metabolites that include 
fatty acids and peroxidized lipids [103].
Lipids modified by ROS and activated oxygen, are 
https://doi.org/10.5534/wjmh.190167
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powerful signal molecules even in plants [104].
For example, oxysterols are fundamental signaling 
molecules in cancer [105,106]. These molecules, occur-
ring as cholesterol oxidized metabolites, may be pro-
duced by radical (ROS-dependent) mechanisms and 
make the so called oxysterome. They are fundamental 
actors in the tissue turnover, including cancer etiol-
ogy, by interacting with a huge panoply of receptors, 
such as nuclear receptors (ROR, ERα, LXR) as well 
as protein G coupled receptors (CXCR2, SMO, EBl2, 
and so on) and becoming fundamental biomarkers in 
many chronic pathologies, including cancer, such as 
4β-hydroxy-cholesterol or 7α-hydroxy-cholestenone [107].
The very recent awareness in science that lipids and 
their metabolytes, together with lipid droplrts, par-
ticipate in the complex signaling language between 
tissues, so having a fundamental role in cancer, have 
put adipose tissue in a strategic focus, an intriguing 
perspective, particularly because adipocytes are able to 
develop stem features. Therefore, the new engagement 
in the biomedical research to highlight any aspects im-
proving men’s health, is to take into consideration this 
fundamental issue.
CONCLUSIONS
This review would simply address some fundamen-
tal “hot topics” that deserve further attention and 
interest in science to attain a real improvement in our 
knowledge on men’s health and the onset of cancer. A 
huge deal of data regarding cancer and nutrition exists 
elsewhere but this manuscript aimed at stressing the 
major items able to drive further investigation towards 
this target, with a simple recommendation. Preventing 
diets from lipids at all, may not be a wise counselling 
to prevent chronic pathologies and cancer. Moderation 
is always advised but lipids are fundamental actors of 
our own health, as they can act as modulatory signal-
ing molecules. Even ROS, in his perspective, may have 
a positive role in promoting health.
Therefore further research is needed to elucidate the 
complex role of ROS and adipose tissue in the different 
dietary habits engaged by humans.
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